LiveMind: Living well through mindfulness

A feasibility randomised controlled trial of a brief mindfulness-based intervention in a mental health secondary care setting

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN16944868

Enrollment

Registered

2016-02-10

Start date

2016-02-12

Completion date

Unknown

Last updated

2016-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Topic: Mental Health

Interventions

Participants are randomly allocated to one of two groups. Intervention group: Participants receive the Live Mind intervention immediately. The LiveMind intervention consists of four weekly group sess

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Aged 18 years old or older 2. Currently in receipt of care from secondary care mental health services in Sussex Partnership NHS Foundation Trust 3. Meet diagnostic criteria for a current DSM IV Axis 1 disorder as assessed by the Mini International Neuropsychiatric Interview (version 6.0)

Exclusion criteria

Exclusion criteria: 1. Misusing substances to the extent that this is likely to adversely influence other members of the mindfulness course (as judged by the person's psychiatrist or care coordinator) 2. Risk of current or recent (past month) active suicidal attempt or intent 3. Have experienced a recent (past month) serious life event/crisis, which would make an MBI inappropriate at the time of referral. 4. Current or planned participation in another form of psychological therapy 5. Taking part in research investigating new medicinal products

Design outcomes

Primary

Measure	Time frame
Feasibility of the intervention is determined at 1 month.	—

Secondary

Measure	Time frame
All outcomes are measured at baseline (pre-randomisation), time 1 (following the end of the immediate-start mindfulness groups) and time 2 (following the end of the delayed-start mindfulness groups). 1. Generalised Anxiety symptom severity. Measured using the Generalised Anxiety Disorder Questionnaire 2. Depression symptom severity. Measured using the Patient Health Questionnaire (PHQ-9) 3. Trait Mindfulness. Measured using the Five Factor Mindfulness Questionnaire Short Form (FFMQ-SF) 4. Self-compassion. Measured using the Self-compassion Scale Short Form (SCS-SF) 5. Wellbeing. Measured using the Short Warwick-Edinburugh Mental Well-being Scale (SWEMEBS)5.	—

Measure

Time frame

All outcomes are measured at baseline (pre-randomisation), time 1 (following the end of the immediate-start mindfulness groups) and time 2 (following the end of the delayed-start mindfulness groups). 1. Generalised Anxiety symptom severity. Measured using the Generalised Anxiety Disorder Questionnaire 2. Depression symptom severity. Measured using the Patient Health Questionnaire (PHQ-9) 3. Trait Mindfulness. Measured using the Five Factor Mindfulness Questionnaire Short Form (FFMQ-SF) 4. Self-compassion. Measured using the Self-compassion Scale Short Form (SCS-SF) 5. Wellbeing. Measured using the Short Warwick-Edinburugh Mental Well-being Scale (SWEMEBS)5.

—

Countries

United Kingdom

Contacts

Public ContactClara Strauss

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026